Statistics
Publications
3
Citations
104
H-Index
3
Active since
2022
Maxence Wynen is an author at UCLouvain specializing in anti-cd20 therapy, immune cell depletion, and chronic inflammation resolution.
Publications per year
2022–2023
3
3
B cell depletion therapy does not resolve chronic active multiple sclerosis lesions
Pietro Maggi, Colin Vanden Bulcke, Edoardo Pedrini et al. · EBioMedicine · 2023 · 83 citations · Full text
Life Sciences, Immunology, Neurology +16
BMAT: An open-source BIDS managing and analysis tool
Colin Vanden Bulcke, Maxence Wynen, Jules Detobel et al. · NeuroImage Clinical · 2022 · 10 citations · Full text
1–3 of 3